Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 11.44x is 65% below its estimated 5-year average of 32.76x, near the low end of its estimated 5-year range (11.44x–47.01x).
As of 2026-10-06T22:35:38.466Z. 67.15% below its estimated 12-month average of 34.83x.
Calculation as of: 2026-10-06T22:35:38.466Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c282ae091baa43953544eb6230b380cd5117f3a7263491550c34677a7a4faed2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
11.44x
EV/EBITDA RATIO AVG TTM
34.83x
EV/EBITDA RATIO AVG 3Y
34.83x
EV/EBITDA RATIO AVG 5Y
32.76x
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-67.15%
CURRENT VS 3Y AVG
-67.15%
CURRENT VS 5Y AVG
-65.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.76x
median of 216 covered companies
CURRENT VS SECTOR MEDIAN
-27.41%
vs the sector median at left
AnaptysBio, Inc.
Market Cap
$1.42B
EV/EBITDA Ratio
11.44x
TTM Avg
34.83x
3Y Avg
34.83x
5Y Avg
32.76x
Market Cap
$1.42B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.40B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.39B
EV/EBITDA Ratio
25.34x
TTM Avg
25.42x
3Y Avg
27.51x
5Y Avg
46.70x
Market Cap
$1.45B
EV/EBITDA Ratio
8.94x
TTM Avg
18.38x
3Y Avg
16.03x
5Y Avg
16.85x
Market Cap
$1.46B
EV/EBITDA Ratio
N/A
TTM Avg
5.67x
3Y Avg
5.67x
5Y Avg
5.67x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.42B | 11.44x | 34.83x | 34.83x | 32.76x |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.44B | 26.24x | 16.63x | 66.61x | 73.09x |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 25.34x | 25.42x | 27.51x | 46.70x |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 8.94x | 18.38x | 16.03x | 16.85x |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | 5.67x | 5.67x | 5.67x |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | N/A | N/A | N/A | N/A |
At 11.4, EV/EBITDA is below its estimated 5-year median — higher than 0% of readings in its estimated 5-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 5-year low
13.9
median
34.4
estimated 5-year high
47.0
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 14.04x |
| 2026-10-02 | 13.86x |
| 2026-10-01 | 13.89x |
| 2026-09-30 | 14.32x |
| 2026-09-29 | 14.35x |
| 2026-09-28 | 14.46x |
| 2026-09-25 | 14.51x |
| 2026-09-24 | 14.70x |
| 2026-09-23 | 14.45x |
| 2026-09-22 | 15.29x |
| 2026-09-21 | 37.12x |
| 2026-09-18 | 37.31x |
| 2026-09-17 | 37.21x |
| 2026-09-16 | 36.72x |
| 2026-09-15 | 36.96x |
| 2026-09-14 | 36.58x |
| 2026-09-11 | 36.42x |
| 2026-09-10 | 37.28x |
| 2026-09-09 | 37.64x |
| 2026-09-08 | 38.24x |
| 2026-09-04 | 38.37x |
| 2026-09-03 | 38.81x |
| 2026-09-02 | 37.73x |
| 2026-09-01 | 37.36x |
| 2026-08-31 | 38.52x |
| 2026-08-28 | 38.02x |
| 2026-08-27 | 38.70x |
| 2026-08-26 | 39.17x |
| 2026-08-25 | 39.41x |
| 2026-08-24 | 39.46x |
| 2026-08-21 | 38.99x |
| 2026-08-20 | 38.30x |
| 2026-08-19 | 40.00x |
| 2026-08-18 | 39.82x |
| 2026-08-17 | 40.29x |
| 2026-08-14 | 39.48x |
| 2026-08-13 | 37.85x |
| 2026-08-12 | 38.49x |
| 2026-08-11 | 39.08x |
| 2026-08-10 | 37.49x |
| 2026-08-07 | 38.24x |
| 2026-08-06 | 37.02x |
| 2026-08-05 | 37.17x |
| 2026-08-04 | 37.26x |
| 2026-08-03 | 36.29x |
| 2026-07-31 | 36.09x |
| 2026-07-30 | 37.20x |
| 2026-07-29 | 35.28x |
| 2026-07-28 | 35.26x |
| 2026-07-27 | 36.25x |
| 2026-07-24 | 36.61x |
| 2026-07-23 | 37.12x |
| 2026-07-22 | 35.59x |
| 2026-07-21 | 36.35x |
| 2026-07-20 | 34.05x |
| 2026-07-17 | 39.17x |
| 2026-07-16 | 36.61x |
| 2026-07-15 | 37.72x |
| 2026-07-14 | 42.16x |
| 2026-07-13 | 47.01x |
| 2026-07-10 | 44.74x |
| 2026-07-09 | 44.87x |
| 2026-07-08 | 44.04x |
| 2026-07-07 | 45.36x |
| 2026-07-06 | 42.03x |
| 2026-07-02 | 42.76x |
| 2026-07-01 | 44.10x |
| 2026-06-30 | 45.47x |
| 2026-06-29 | 44.46x |
| 2026-06-26 | 42.58x |
| 2026-06-25 | 40.28x |
| 2026-06-24 | 39.48x |
| 2026-06-23 | 40.12x |
| 2026-06-22 | 40.49x |
| 2026-06-18 | 38.84x |
| 2026-06-17 | 38.35x |
| 2026-06-16 | 38.91x |
| 2026-06-15 | 40.17x |
| 2026-06-12 | 37.89x |
| 2026-06-11 | 36.67x |
| 2026-06-10 | 35.25x |
| 2026-06-09 | 34.94x |
| 2026-06-08 | 34.76x |
| 2026-06-05 | 34.10x |
| 2026-06-04 | 34.96x |
| 2026-06-03 | 34.68x |
| 2026-06-02 | 34.69x |
| 2026-06-01 | 35.94x |
| 2026-05-29 | 37.62x |
| 2026-05-28 | 38.52x |
| 2026-05-27 | 38.96x |
| 2026-05-26 | 39.01x |
| 2026-05-22 | 40.30x |
| 2026-05-21 | 40.77x |
| 2026-05-20 | 40.55x |
| 2026-05-19 | 40.34x |
| 2026-05-18 | 39.66x |
| 2026-05-15 | 42.58x |
| 2026-05-14 | 41.95x |
| 2026-05-13 | 42.28x |
| 2026-05-12 | 41.89x |
| 2026-05-11 | 43.35x |
| 2026-05-08 | 44.23x |
| 2026-05-07 | 42.75x |
| 2026-05-06 | 43.00x |
| 2026-05-05 | 44.20x |
| 2026-05-04 | 44.51x |
| 2026-05-01 | 42.63x |
| 2026-04-30 | 41.98x |
| 2026-04-29 | 39.87x |
| 2026-04-28 | 42.22x |
| 2026-04-27 | 42.52x |
| 2026-04-24 | 37.72x |
| 2026-04-23 | 32.98x |
| 2026-04-22 | 34.40x |
| 2026-04-21 | 33.32x |
| 2026-04-20 | 32.78x |
| 2026-04-17 | 29.07x |
| 2026-04-16 | 28.82x |
| 2026-04-15 | 29.23x |
| 2026-04-14 | 30.20x |
| 2026-04-13 | 29.58x |
| 2026-04-10 | 30.15x |
| 2026-04-09 | 29.50x |
| 2026-04-08 | 28.26x |
| 2026-04-07 | 26.84x |
| 2026-04-06 | 26.96x |
| 2026-04-02 | 24.99x |
| 2026-04-01 | 24.59x |
| 2026-03-31 | 24.07x |
| 2026-03-30 | 24.04x |
| 2026-03-27 | 24.87x |
| 2026-03-26 | 28.03x |
| 2026-03-25 | 28.19x |
| 2026-03-24 | 27.21x |
| 2026-03-23 | 27.09x |
| 2026-03-20 | 26.94x |
| 2026-03-19 | 27.92x |
| 2026-03-18 | 27.92x |
| 2026-03-17 | 28.98x |
| 2026-03-16 | 27.94x |
| 2026-03-13 | 27.96x |
| 2026-03-12 | 27.53x |
| 2026-03-11 | 27.89x |
| 2026-03-10 | 26.79x |
| 2026-03-09 | 25.83x |
| 2026-03-06 | 24.05x |
| 2026-03-05 | 24.83x |
| 2026-03-04 | 26.19x |
| 2022-03-07 | 24.47x |
| 2022-03-04 | 24.95x |
| 2022-03-03 | 24.38x |
| 2022-03-02 | 25.88x |
| 2022-03-01 | 24.95x |
| 2022-02-28 | 25.56x |
| 2022-02-25 | 27.20x |
| 2022-02-24 | 27.77x |
| 2022-02-23 | 24.32x |
| 2022-02-22 | 25.47x |
| 2022-02-18 | 24.47x |
| 2022-02-17 | 24.32x |
| 2022-02-16 | 26.16x |
| 2022-02-15 | 27.11x |
| 2022-02-14 | 25.30x |
| 2022-02-11 | 24.44x |
| 2022-02-10 | 25.30x |
| 2022-02-09 | 28.98x |
| 2022-02-08 | 26.68x |
| 2022-02-07 | 27.77x |
| 2022-02-04 | 27.08x |
| 2022-02-03 | 24.64x |
| 2022-02-02 | 26.62x |
| 2022-02-01 | 28.06x |
| 2022-01-31 | 28.23x |
| 2022-01-28 | 26.91x |
| 2022-01-27 | 24.44x |
| 2022-01-26 | 27.17x |
| 2022-01-25 | 29.27x |
| 2022-01-24 | 29.21x |
| 2022-01-21 | 26.36x |
| 2022-01-20 | 26.59x |
| 2022-01-19 | 28.75x |
| 2022-01-18 | 28.78x |
| 2022-01-14 | 31.63x |
| 2022-01-13 | 29.70x |
| 2022-01-12 | 33.58x |
| 2022-01-11 | 34.45x |
| 2022-01-10 | 31.95x |
| 2022-01-07 | 29.76x |
| 2022-01-06 | 31.80x |
| 2022-01-05 | 29.85x |
| 2022-01-04 | 34.53x |
| 2022-01-03 | 35.86x |
| 2021-12-31 | 33.58x |
| 2021-12-30 | 34.65x |
| 2021-12-29 | 34.36x |
| 2021-12-28 | 35.83x |
| 2021-12-27 | 36.92x |
| 2021-12-23 | 38.02x |
| 2021-12-22 | 36.52x |
| 2021-12-21 | 35.51x |
| 2021-12-20 | 36.29x |
| 2021-12-17 | 35.14x |
| 2021-12-16 | 34.65x |
| 2021-12-15 | 33.61x |
| 2021-12-14 | 27.11x |
| 2021-12-13 | 26.80x |
| 2021-12-10 | 24.47x |
| 2021-12-09 | 24.47x |
| 2021-12-08 | 26.91x |
| 2021-12-07 | 26.51x |
| 2021-12-06 | 25.67x |
| 2021-12-03 | 24.84x |
| 2021-12-02 | 27.66x |
| 2021-12-01 | 26.80x |
| 2021-11-30 | 28.98x |
| 2021-11-29 | 25.70x |
| 2021-11-26 | 26.62x |
| 2021-11-24 | 27.92x |
| 2021-11-23 | 27.03x |
| 2021-11-22 | 25.88x |
| 2021-11-19 | 25.99x |
| 2021-11-18 | 27.49x |
| 2021-11-17 | 27.86x |
| 2021-11-16 | 27.89x |
| 2021-11-15 | 28.58x |
| 2021-11-12 | 29.73x |
| 2021-11-11 | 30.71x |
| 2021-11-10 | 32.00x |
| 2021-11-09 | 34.05x |
| 2021-11-08 | 38.76x |
| 2021-11-05 | 38.02x |
